NCT03904485|Unknown
Assessment of Myocardial Injury in Simultaneous Pancreas and Kidney Transplantation
AMI-SPK
Loading search results
AMI-SPK
Sponsor study identifier
observational
50
1 country
1
Study Start
April 1, 2019
Actual (reported)Primary Completion
April 1, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Diabetic cardiomyopathy( DCM) is a major complication of diabetes and is a common cardiovascular complication independent of coronary artery disease and hypertension．Trial to assess of myocardial injury in recipients of simultaneous pancreas and kidney transplantation by nuclear magnetic T２ mapping technology.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 1, 2019
Actual (reported)April 4, 2019
Actual (reported)April 5, 2019
Actual (reported)April 1, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
April 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Assessment of myocardial injury
Assessment of myocardial injury between two groups
1year
patients with end-stage diabetic nephropathy got simultaneous pancreas-kidney transplantation
patients with end-stage diabetic nephropathy got single kidney transplantation
T2 value before transplant，3 month and 6month after transplant
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
A total of 25 patients with SPK who met the inclusion criteria and 25 patients with simple kidney transplantation for diabetic end-stage nephropathy were included by matching the onset time, gender, age, BMI and blood pressure of diabetes
Tianjin First central hospital
Tianjin, China
Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004 Jul;52(1):141-6. doi: 10.1002/mrm.20110.
Ding H, Fernandez-de-Manuel L, Schar M, Schuleri KH, Halperin H, He L, Zviman MM, Beinart R, Herzka DA. Three-dimensional whole-heart T2 mapping at 3T. Magn Reson Med. 2015 Sep;74(3):803-16. doi: 10.1002/mrm.25458. Epub 2014 Sep 19.
First Submitted
April 4, 2019
First Posted
April 5, 2019
Study Start
April 1, 2019
Actual (reported)Primary Completion
April 1, 2020
Estimated (date passed)Diabetic Cardiomyopathy
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 5, 2019
Record last verified: 2019-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: